1.
Transthyretin Silencing Therapies and the Cardiology Clinic: Selection, Cost and the Diagnostic Bottleneck Upstream. JHCS [Internet]. 2023 Nov. 17 [cited 2026 Oct. 30];4(1):1-4. Available from: https://pragmajournals.org/index.php/JHCS/article/view/171